|
WO2016149137A1
|
|
High throughput monoclonal antibody generation by b cell panning and proliferation
|
|
WO2015026606A1
|
|
Antibody identification by lineage analysis
|
|
AU2014202474A1
|
|
Anti-VEGF antibody
|
|
WO2013009767A2
|
|
Facs-based method for obtaining an antibody sequence
|
|
CN102140097A
|
|
Azaoxindole and synthetic method thereof
|
|
CN102058613A
|
|
New application of antineoplastic constituent compound in solanum nigrum
|
|
CN102093194A
|
|
New method for synthesizing 3-cyclopropyl methoxy-4-(difluoromethoxy) benzoic acid
|
|
CN102000080A
|
|
Method for solubilizing camptothecin compound
|
|
CN102040570A
|
|
Sulfo-taxane derivative and preparation method and application thereof
|
|
CN102002063A
|
|
Dipeptide boric acid consisting of carboxylic acid and beta amino acid, and ester compound, preparation method and usage thereof
|
|
CN102002104A
|
|
Anti-VEGF monoclonal antibody and medicinal composition containing same
|
|
CN101935316A
|
|
Quinazoline compound and application thereof
|
|
CA2721983A1
|
|
Anti-tnf (alpha) antibody
|
|
CN101781369A
|
|
Recombinant human arginase fusion protein and application thereof
|
|
KR20100132983A
|
|
Anti-vegf antibody
|
|
US2007015259A1
|
|
Fusion partner for production of monoclonal rabbit antibodies
|
|
US2006216293A1
|
|
TNFα-neutralizing antibodies
|
|
US2005287118A1
|
|
Bacterial plasmid with immunological adjuvant function and uses thereof
|
|
US2005277127A1
|
|
High-throughput method of DNA immunogen preparation and immunization
|
|
US2006099204A1
|
|
Methods for antibody engineering
|
